Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1989 March; 82(3): 153–158.
PMCID: PMC1292041

Autoimmunity in Graves' ophthalmopathy: a review.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Jacobson DH, Gorman CA. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment. Endocr Rev. 1984 Spring;5(2):200–220. [PubMed]
  • Amino N, Yuasa T, Yabu Y, Miyai K, Kumahara Y. Exophthalmos in autoimmune thyroid disease. J Clin Endocrinol Metab. 1980 Dec;51(6):1232–1234. [PubMed]
  • Enzmann DR, Donaldson SS, Kriss JP. Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr. 1979 Dec;3(6):815–819. [PubMed]
  • Mauri L, Meienberg O, Roth E, König MP. Evaluation of endocrine ophthalmopathy with saccadic eye movements. J Neurol. 1984;231(4):182–187. [PubMed]
  • Gamblin GT, Harper DG, Galentine P, Buck DR, Chernow B, Eil C. Prevalence of increased intraocular pressure in Graves' disease--evidence of frequent subclinical ophthalmopathy. N Engl J Med. 1983 Feb 24;308(8):420–424. [PubMed]
  • Allen C, Stetz D, Roman SH, Podos S, Som P, Davies TF. Prevalence and clinical associations of intraocular pressure changes in Graves' disease. J Clin Endocrinol Metab. 1985 Jul;61(1):183–187. [PubMed]
  • Teng CS, Yeo PP. Ophthalmic Graves's disease: natural history and detailed thyroid function studies. Br Med J. 1977 Jan 29;1(6056):273–275. [PMC free article] [PubMed]
  • Gwinup G, Elias AN, Ascher MS. Effect on exophthalmos of various methods of treatment of Graves' disease. JAMA. 1982 Apr 16;247(15):2135–2138. [PubMed]
  • Weetman AP, McGregor AM. Autoimmune thyroid disease: developments in our understanding. Endocr Rev. 1984 Spring;5(2):309–355. [PubMed]
  • Hägg E, Asplund K. Is endocrine ophthalmopathy related to smoking? Br Med J (Clin Res Ed) 1987 Sep 12;295(6599):634–635. [PMC free article] [PubMed]
  • Teng CS, Smith BR, Clayton B, Evered DC, Clark F, Hall R. Thyroid-stimulating immunoglobulins in ophthalmic Graves' disease. Clin Endocrinol (Oxf) 1977 Mar;6(3):207–211. [PubMed]
  • Trokel SL, Jakobiec FA. Correlation of CT scanning and pathologic features of ophthalmic Graves' disease. Ophthalmology. 1981 Jun;88(6):553–564. [PubMed]
  • Daicker B. Das gewebliche Substrat der verdickten äussberen Augenmuskeln bei der endokrinen Orbitopathie. Klin Monbl Augenheilkd. 1979 Jun;174(6):843–847. [PubMed]
  • Sisson JC, Vanderburg JA. Lymphocyte-retrobulbar fibroblast interaction: mechanisms by which stimulation occurs and inhibition of stimulation. Invest Ophthalmol. 1972 Jan;11(1):15–20. [PubMed]
  • Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB. Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci U S A. 1985 Jan;82(1):119–123. [PubMed]
  • Ramsay ID. Muscle dysfunction in hyperthyroidism. Lancet. 1966 Oct 29;2(7470):931–934. [PubMed]
  • Mashieu P, Winand R. Demonstration of delayed hypersensitivity to retrobulbar and thyroid tissues in human exophthalmos. J Clin Endocrinol Metab. 1972 Jun;34(6):1090–1092. [PubMed]
  • Munro RE, Lamki L, Row VV, Volpé R. Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test. J Clin Endocrinol Metab. 1973 Aug;37(2):286–292. [PubMed]
  • Mullin BR, Levinson RE, Friedman A, Henson DE, Winand RJ, Kohn LD. Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Endocrinology. 1977 Feb;100(2):351–366. [PubMed]
  • Konishi J, Herman MM, Kriss JP. Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology. 1974 Aug;95(2):434–446. [PubMed]
  • Wall JR, Trewin A, Fang SL, Ingbar SH, Braverman LE. Studies of immunoreactivity to human lacrimal gland fractions in patients with ophthalmic Graves' disease. J Endocrinol Invest. 1978 Jul;1(3):253–258. [PubMed]
  • Wall JR, Strakosch CR, Fang SL, Ingbar SH, Braverman LE. Thyroid binding antibodies and other immunological abnormalities in patients with Graves' ophthalmopathy: effect of treatment with cyclophosphamide. Clin Endocrinol (Oxf) 1979 Jan;10(1):79–91. [PubMed]
  • Wall JR, Walters BA, Grant C. Luekocyte adherence inhibition in response to human orbital and lacrimal extracts in patients with Graves' ophthalmopathy. J Endocrinol Invest. 1979 Oct-Dec;2(4):375–378. [PubMed]
  • Melis GB, Mais V, Paoletti AM, Beneventi F, Petacchi FD, Fioretti P. Involvement of endogenous gabaergic system in the modulation of gonadotropin secretion in normal cycling women. J Endocrinol Invest. 1986 Feb;9(1):71–76. [PubMed]
  • Blau HM, Kaplan I, Tao TW, Kriss JP. Thyroglobulin-independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy. Life Sci. 1983 Jan 3;32(1-2):45–53. [PubMed]
  • Wang PW, Hiromatsu Y, Laryea E, Wosu L, How J, Wall JR. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy. J Clin Endocrinol Metab. 1986 Aug;63(2):316–322. [PubMed]
  • Hiromatsu Y, Fukazawa H, How J, Wall JR. Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy--roles of class II MHC antigen expression and gamma-interferon action of effector and target cells. Clin Exp Immunol. 1987 Dec;70(3):593–603. [PubMed]
  • Henderson J, Wall JR. Failure of haemagglutination and immunofluorescence methods to detect serum orbital antibodies in patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1981 Feb;14(2):153–158. [PubMed]
  • Mengistu M, Laryea E, Miller A, Wall JR. Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluorescence. Clin Exp Immunol. 1986 Jul;65(1):19–27. [PubMed]
  • Kodama K, Sikorska H, Bandy-Dafoe P, Bayly R, Wall JR. Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves' ophthalmopathy. Lancet. 1982 Dec 18;2(8312):1353–1356. [PubMed]
  • Kendall-Taylor P, Atkinson S, Holcombe M. A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity. Br Med J (Clin Res Ed) 1984 Apr 21;288(6425):1183–1186. [PMC free article] [PubMed]
  • Atkinson S, Holcombe M, Kendall-Taylor P. Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy. Lancet. 1984 Aug 18;2(8399):374–376. [PubMed]
  • Faryna M, Nauman J, Gardas A. Measurement of autoantibodies against human eye muscle plasma membranes in Graves' ophthalmopathy. Br Med J (Clin Res Ed) 1985 Jan 19;290(6463):191–192. [PMC free article] [PubMed]
  • Sikorska H, Wall JR. Failure to detect eye muscle membrane specific autoantibodies in Graves' ophthalmopathy. Br Med J (Clin Res Ed) 1985 Aug 31;291(6495):604–604. [PMC free article] [PubMed]
  • Kadlubowski M, Irvine WJ, Rowland AC. The lack of specificity of ophthalmic immunoglobulins in Graves' disease. J Clin Endocrinol Metab. 1986 Oct;63(4):990–995. [PubMed]
  • Ahmann A, Baker JR, Jr, Weetman AP, Wartofsky L, Nutman TB, Burman KD. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay. J Clin Endocrinol Metab. 1987 Mar;64(3):454–460. [PubMed]
  • Kadlubowski M, Irvine WJ, Rowland AC. Anti-muscle antibodies in Graves' ophthalmopathy. J Clin Lab Immunol. 1987 Nov;24(3):105–111. [PubMed]
  • Kendall-Taylor P, Jones D, Atkinson S. The specificity of autoantibodies in Graves' ophthalmopathy. Acta Endocrinol Suppl (Copenh) 1987;281:330–333. [PubMed]
  • Kodama K, Sikorska H, Bayly R, Bandy-Dafoe P, Wall JR. Use of monoclonal antibodies to investigate a possible role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy. J Clin Endocrinol Metab. 1984 Jul;59(1):67–73. [PubMed]
  • Kuroki T, Ruf J, Whelan L, Miller A, Wall JR. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders. Clin Exp Immunol. 1985 Nov;62(2):361–370. [PubMed]
  • Tao TW, Cheng PJ, Pham H, Leu SL, Kriss JP. Monoclonal antithyroglobulin antibodies derived from immunizations of mice with human eye muscle and thyroid membranes. J Clin Endocrinol Metab. 1986 Sep;63(3):577–582. [PubMed]
  • Schumacher M, Camp S, Maulet Y, Newton M, MacPhee-Quigley K, Taylor SS, Friedmann T, Taylor P. Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence. Nature. 319(6052):407–409. [PubMed]
  • Ludgate M, Swillens S, Mercken L, Vassart G. Homology between thyroglobulin and acetylcholinesterase: an explanation for pathogenesis of Graves' ophthalmopathy? Lancet. 1986 Jul 26;2(8500):219–220. [PubMed]
  • Weetman AP, Tse CK, Randall WR, Tsim KW, Barnard EA. Acetylcholinesterase antibodies and thyroid autoimmunity. Clin Exp Immunol. 1988 Jan;71(1):96–99. [PubMed]
  • Rotella CM, Zonefrati R, Toccafondi R, Valente WA, Kohn LD. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metab. 1986 Feb;62(2):357–367. [PubMed]
  • Bahn RS, Gorman CA, Woloschak GE, David CS, Johnson PM, Johnson CM. Human retroocular fibroblasts in vitro: a model for the study of Graves' ophthalmopathy. J Clin Endocrinol Metab. 1987 Oct;65(4):665–670. [PubMed]
  • Farid NR, Stone E, Johnson G. Graves' disease and HLA: clinical and epidemiologic associations. Clin Endocrinol (Oxf) 1980 Dec;13(6):535–544. [PubMed]
  • Schleusener H, Schernthaner G, Mayr WR, Kotulla P, Bogner U, Finke R, Meinhold H, Koppenhagen K, Wenzel KW. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter. J Clin Endocrinol Metab. 1983 Apr;56(4):781–785. [PubMed]
  • Frecker M, Stenszky V, Balazs C, Kozma L, Kraszits E, Farid NR. Genetic factors in Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1986 Nov;25(5):479–485. [PubMed]
  • Bech K, Lumholtz B, Nerup J, Thomsen M, Platz P, Ryder LP, Svejgaard A, Siersbaek-Nielsen K, Hansen JM, Larsen JH. HLA antigens in Graves' disease. Acta Endocrinol (Copenh) 1977 Nov;86(3):510–516. [PubMed]
  • Allannic H, Fauchet R, Lorcy Y, Heim J, Gueguen M, Leguerrier AM, Genetet B. HLA and Graves' disease: an association with HLA-DRw3. J Clin Endocrinol Metab. 1980 Oct;51(4):863–867. [PubMed]
  • Weetman AP, So AK, Warner CA, Foroni L, Fells P, Shine B. Immunogenetics of Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1988 Jun;28(6):619–628. [PubMed]
  • Sridama V, Hara Y, Fauchet R, DeGroot LJ. HLA immunogenetic heterogeneity in black American patients with Graves' disease. Arch Intern Med. 1987 Feb;147(2):229–231. [PubMed]
  • Sergott RC, Felberg NT, Savino PJ, Blizzard JJ, Schatz NJ, Sanford CA. Association of HLA antigen BW35 with severe Graves' ophthalmopathy. Invest Ophthalmol Vis Sci. 1983 Jan;24(1):124–127. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press